These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19149554)

  • 21. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection.
    Polyanskaya N; Sharpe S; Cook N; Leech S; Banks J; Dennis M; Hall G; Stott J; Cranage M
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):923-31. PubMed ID: 9223408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
    Gabriel B; Fiebig U; Hohn O; Plesker R; Coulibaly C; Cichutek K; Mühlebach MD; Bannert N; Kurth R; Norley S
    Virology; 2016 Feb; 489():1-11. PubMed ID: 26685794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines.
    Jones L; Ahmad S; Chan K; Verardi P; Morton WR; Grant R; Yilma T
    J Med Primatol; 2000 Aug; 29(3-4):231-9. PubMed ID: 11085585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increases in NKG2C Expression on T Cells and Higher Levels of Circulating CD8
    Hodara VL; Parodi LM; Keckler MS; Giavedoni LD
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1125-1134. PubMed ID: 26986800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine.
    Putkonen P; Walther L; Zhang YJ; Li SL; Nilsson C; Albert J; Biberfeld P; Thorstensson R; Biberfeld G
    Nat Med; 1995 Sep; 1(9):914-8. PubMed ID: 7585217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.
    Genescà M; McChesney MB; Miller CJ
    J Intern Med; 2009 Jan; 265(1):67-77. PubMed ID: 19093961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.
    Wyand MS; Manson K; Montefiori DC; Lifson JD; Johnson RP; Desrosiers RC
    J Virol; 1999 Oct; 73(10):8356-63. PubMed ID: 10482586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live attenuated SIV vaccines are not effective in a postexposure vaccination model.
    Linhart H; Gundlach BR; Sopper S; Dittmer U; Mätz-Rensing K; Kuhn EM; Müller J; Hunsmann G; Stahl-Hennig C; Uberla K
    AIDS Res Hum Retroviruses; 1997 May; 13(7):593-9. PubMed ID: 9135877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.
    Crotty S; Miller CJ; Lohman BL; Neagu MR; Compton L; Lu D; Lü FX; Fritts L; Lifson JD; Andino R
    J Virol; 2001 Aug; 75(16):7435-52. PubMed ID: 11462016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel application of nonhuman primate tethering system for evaluation of acute phase SIVmac251 infection in rhesus macaques (Macaca mulatta).
    Keckler MS; Hodara VL; Parodi LM; Giavedoni LD
    Viral Immunol; 2007 Dec; 20(4):623-34. PubMed ID: 18158735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.
    Yang GB; Wang Y; Babaahmady K; Schøller J; Rahman D; Bunnik E; Spallek R; Zong CM; Duan JZ; Qin C; Jiang H; Singh M; Vaughan R; Bergmeier LA; Schuitemaker H; Shao Y; Lehner T
    J Gen Virol; 2012 Jul; 93(Pt 7):1506-1518. PubMed ID: 22492918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
    Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
    J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.